الصناعة الدوائية

Eli Lilly Opposes White House Efforts to Legislate Drug Pricing

Eli Lilly's CEO, Dave Ricks, announced the company's opposition to the White House's efforts to legislate a 'most favored nation' policy for drug pricing. This comes as the U.S. administration seeks to affirm lower drug prices in the American market.